Journal
LANCET GASTROENTEROLOGY & HEPATOLOGY
Volume 5, Issue 6, Pages 598-606Publisher
ELSEVIER INC
DOI: 10.1016/S2468-1253(20)30119-9
Keywords
-
Categories
Funding
- NIHR Birmingham Biomedical Research Centre University Hospitals Birmingham NHS Foundation Trust
- University of Birmingham
Ask authors/readers for more resources
The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available